• Trillion Dollar Shot, Episode 1: Birth of a Blockbuster

  • May 13 2024
  • Duración: 42 m
  • Podcast
Trillion Dollar Shot, Episode 1: Birth of a Blockbuster Por arte de portada

Trillion Dollar Shot, Episode 1: Birth of a Blockbuster

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Before Ozempic, Wegovy, Mounjaro and Zepbound, there was Lotte Bjerre Knudsen. In the 1990s, the young scientist at the Danish drug company Novo Nordisk was trying to unlock the key to a new technology for treating Type 2 diabetes. To her bosses, Lotte’s project, which focused on a hormone called GLP-1, looked like a distraction. But as Lotte fought to save her diabetes project from the chopping block, she couldn’t have imagined how much of an impact her breakthrough would have. Her work would pave the way for a hit drug called Ozempic. And it would unleash a new class of blockbuster drugs, pitting two companies in a race to become the world’s first trillion-dollar pharmaceutical company by market cap. Listen to Part 1 of “Trillion Dollar Shot” now. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
Empresas y Profesiones Política y Gobierno
Más Menos

Lo que los oyentes dicen sobre Trillion Dollar Shot, Episode 1: Birth of a Blockbuster

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles